Legal & General Group Plc

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 764068 London, X0

Position in BDTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,443

+$2,515 QoQ

Shares Held

4,564

+19.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 96 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. BDTX ranks #283 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,443	4,564	+19.3%	Shares	Defined	2026-08-14
2025-03-31	$5,928	3,825	0.0%	Shares	Defined	2025-05-15
2024-12-31	$8,185	3,825	0.0%	Shares	Defined	2025-02-13
2024-09-30	$16,638	3,825	0.0%	Shares	Defined	2025-02-28
2024-06-30	$17,824	3,825	+110.7%	Shares	Defined	2025-05-29
2022-03-31	$5,027	1,815	0.0%	Shares	Defined	2022-05-16
2021-12-31	$9,673	1,815	-71.9%	Shares	Defined	2022-02-14
2021-09-30	$54,718	6,468	+194.1%	Shares	Defined	2021-11-15
2021-06-30	$26,804	2,199	-26.3%	Shares	Defined	2021-08-12
2021-03-31	$72,414	2,985	+17.6%	Shares	Defined	2021-05-17
2020-12-31	$81,374	2,539	0.0%	Shares	Defined	2021-02-12
2020-09-30	$76,753	2,539	+7.0%	Shares	Defined	2020-11-13
2020-06-30	$100,087	2,374	+27.0%	Shares	Defined	2020-08-14
2020-03-31	$46,656	1,870	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.